Company / Gross Profit
Indivior Gross Profit History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$994.0M
FY2025
5-year range
$749.0M / $994.0M
FY2022-FY2025
Trend
+3.9%
vs FY2024
Sector context
#10 of 29
Health Care
What the data says
At $994M, Indivior's gross profit ranks #10 of 29 in the Health Care sector. Gross Profit has increased for 3 consecutive years, from $749M in FY2022 to $994M in FY2025.
Based on SEC 10-K filings.
$994M in FY2025 with a 3-year CAGR of +9.9%.
Improved from $919M to $994M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +9.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#10 of 29 in Health CareTop 34% of 29This company $994.0M Sector average $3.5B
▼
-71.3% below sector average
Key checks
Key Insights
- Indivior's gross profit has grown for 3 consecutive years.
- 3-year CAGR of +9.9%, indicating consistent growth.
- In FY2025, gross profit increased 3.9% year-over-year.
- Ranks #10 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $994.0M | +3.9% |
| FY2024 | $957.0M | +4.1% |
| FY2023 | $919.0M | +22.7% |
| FY2022 | $749.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026